Regulation of Candida albicans morphogenesis by tumor necrosis factor-alpha and potential for treatment of oral candidiasis

In Vivo. 2007 Jan-Feb;21(1):25-32.

Abstract

Background: Endogenous tumor necrosis factor-alpha (TNF-alpha) has a beneficial effect as an activation mediator of host defense against infection by the fungus Candida albicans (C. albicans). However, it is unclear whether exogenous TNF-alpha has a beneficial or detrimental effect against Candida.

Materials and methods: The direct effect of TNF-alpha on CO2-induced morphological transformation of C. albicans blastoconidia was examined in vitro and the effect of TNF-alpha was determined in a mouse model of oral candidiasis.

Results: TNF-alpha suppressed hyphal formation from C. albicans blastoconidia directly and dose-dependently, whereas it did not affect the fungal budding rate at concentrations ranging from 0.01 to 10 microg/ml. In vivo, the oral administration of TNF-alpha significantly reduced the C. albicans CFU in tongue tissues of treated mice. Histopathologically, there was a decrease in the number and size of C. albicans fungi in the tongue tissues.

Conclusion: Since orally administered TNF-alpha suppressed fungal burden in the tongue tissue without significant detrimental effects, TNF-alpha has potential as a therapeutic agent against Candida.

MeSH terms

  • Animals
  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use*
  • Candida albicans / drug effects*
  • Candida albicans / growth & development
  • Candida albicans / physiology
  • Candidiasis, Oral / drug therapy*
  • Candidiasis, Oral / microbiology
  • Carbon Dioxide / pharmacology
  • Disease Models, Animal
  • Female
  • Humans
  • Mice
  • Mice, Inbred ICR
  • Tongue / drug effects
  • Tongue / microbiology
  • Tumor Necrosis Factor-alpha / pharmacology
  • Tumor Necrosis Factor-alpha / therapeutic use*

Substances

  • Antifungal Agents
  • Tumor Necrosis Factor-alpha
  • Carbon Dioxide